| Stage | LLY | % of rev | ANIP | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $24.4B | 100.00% | $291M | 100.00% | LLY ×83.90 |
| Gross profit | $20.5B | 83.88% | $179M | 61.64% | LLY +22.2pp |
| Operating income | $8.6B | 35.28% | $52M | 18.01% | LLY +17.3pp |
| Pre-tax income | $8.4B | 34.46% | $49M | 16.87% | LLY +17.6pp |
| Net income | $6.5B | 26.44% | $35M | 12.09% | LLY +14.4pp |
| Stage | LLY | ANIP | Gap · A − B |
|---|---|---|---|
| Revenue | $24.4B100.00% | $291M100.00% | LLY ×83.90 |
| Gross profit | 83.88%$20.5B | 61.64%$179M | LLY +22.2pp |
| Operating income | 35.28%$8.6B | 18.01%$52M | LLY +17.3pp |
| Pre-tax income | 34.46%$8.4B | 16.87%$49M | LLY +17.6pp |
| Net income |
| 26.44%$6.5B |
| 12.09%$35M |
| LLY +14.4pp |
LLY 10-KFeb 12 '26
“In 2025, 2024, and 2023, three wholesale distributors in the U.S.—McKesson Corporation, Cencora, Inc., and Cardinal Health, Inc.—each accounted for a significant percentage of our consolidated revenue.”
ANIP 10-KFeb 27 '26
“We conduct business with the three major wholesalers in the U.S.: Cencora, Inc., Cardinal Health, and McKesson.”
LLY 10-KFeb 12 '26
“In 2025, 2024, and 2023, three wholesale distributors in the U.S.—McKesson Corporation, Cencora, Inc., and Cardinal Health, Inc.—each accounted for a significant percentage of our consolidated revenue.”
ANIP 10-KFeb 27 '26
“We conduct business with the three major wholesalers in the U.S.: Cencora, Inc., Cardinal Health, and McKesson.”